Abacavir (Ziagen) Oral solution: Discontinuation

Discontinuation Active

The supplier, GSK New Zealand, has discontinued Ziagen 20 mg/mL (abacavir) oral solution (Pharmacode 2014718).

Affected product

The supplier has discontinued Ziagen 20 mg/mL (abacavir) oral solution (Pharmacode 2014718). There will be no more stock arriving. The current stock in Aotearoa New Zealand will expire on 30 June 2024.

We will be delisting Ziagen 20 mg/mL (abacavir) oral solution (Pharmacode 2014718) from 1 July 2024

  • Chemical: Abacavir sulphate
  • Presentation: Oral liq 20 mg per ml
  • Brand: Ziagen
  • Pharmacode: 2014718 
  • Subsidy: $256.31
  • Measure / Qty: per 240 ml OP 

Schedule listing for Ziagen(external link)

Alternative product

The 300 mg tablets of Ziagen brand abacavir sulphate remain available. People will not need a new prescription. Pharmacists can dispense a different presentation when it is not practical to dispense the prescribed presentation.

Rule 3.4 of the Schedule

Who to contact

If you have questions about this issue, email enquiry@pharmac.govt.nz

Please include as much information as you can about the product (presentation, brand, pharmacode) and who your wholesaler is.  

Sign up to our email list for regular emails about supply issues and more(external link)